CXBS — Corix Bioscience Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Corix Bioscience, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2012 January 31st	2013 January 31st	2014 January 31st	2015 January 31st	2016 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-0.076	-1.7	-1.72	-0.057	-4.43
Depreciation
Non-Cash Items	0.006	1.68	1.7	0.02	2.37
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.062	0.008	0.01	0.017	0.053
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities	-0.008	-0.008	-0.012	-0.02	-1.85
Capital Expenditures	—	—	—	—	-0.028
Purchase of Fixed Assets
Other Investing Cash Flow Items	—	—	—	—	0.097
Sale of Fixed Assets
Sale/Maturity of Investment
Cash from Investing Activities	—	—	—	—	0.069
Financing Cash Flow Items	0.008	0	0	—	0.572
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.008	0.008	0.012	0.021	1.58
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0	-0	0	0	-0.197